J9173 HCPCS code: Injection, durvalumab, 10 mg
J9173 is the HCPCS Level II code for injection, durvalumab, 10 mg. In 2024 Medicare paid an average of $62.94 per service for J9173 across 3,686,905 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 150 per day on outpatient hospital claims. Medicare volume rose 34% from 2022 to 2024 (2,746,557 to 3,686,905 services). In 2024, about 3,250 clinicians billed Medicare for J9173 for 5,256 beneficiaries; Florida, Texas, California accounted for 35% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2019-01-01 |
| Last action effective | 2019-01-01 |
Who bills J9173 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 3,250 |
| Medicare beneficiaries | 5,256 |
| States with claims | 43 |
| Share of services in top 3 states (Florida, Texas, California) | 35% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J9173, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 2,746,557 | 3,962 | $75.74 | $60.44 |
| 2023 | 3,464,120 | 4,862 | $76.88 | $61.25 |
| 2024 | 3,686,905 | 5,256 | $79.01 | $62.94 |
States with the most J9173 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 496,173 | $63.20 |
| Texas | 440,517 | $63.18 |
| California | 330,119 | $62.75 |
| Illinois | 187,047 | $62.93 |
| Virginia | 177,943 | $63.68 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 150 | Prescribing Information |
| practitioner claims | 150 | Prescribing Information |
What changed for J9173
- 2019-01-01: J9173 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J9173?
J9173 is the HCPCS Level II code for injection, durvalumab, 10 mg. Short descriptor: "Inj., durvalumab, 10 mg".
How much does Medicare pay for J9173?
In 2024, the average Medicare payment was $62.94 per service (average allowed $79.01).
Does Medicare cover J9173?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J9173 can be billed per day?
150 on outpatient hospital claims; 150 on practitioner claims (NCCI medically unlikely edits).
Related J91 codes
- J9100 — Injection, cytarabine, 100 mg
- J9118 — Injection, calaspargase pegol-mknl, 10 units
- J9119 — Injection, cemiplimab-rwlc, 1 mg
- J9120 — Injection, dactinomycin, 0.5 mg
- J9130 — Dacarbazine, 100 mg
- J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj
- J9145 — Injection, daratumumab, 10 mg
- J9150 — Injection, daunorubicin, 10 mg
- J9151 — Injection, daunorubicin citrate, liposomal formulation, 10 mg
- J9153 — Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine
- J9155 — Injection, degarelix, 1 mg
- J9160 — Injection, denileukin diftitox, 300 micrograms
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J9173
- Watch J9173 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J9173
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.